Key result
Respiratory-only extracorporeal support is linked to ~41% lower hospital mortality in ARDS versus combined support.
Why the study?
Venovenous extracorporeal membrane oxygenation is established for severe ARDS, but some patients also develop circulatory failure requiring cardiac or cardiorespiratory extracorporeal life support, and mortality in this group is poorly defined.
Does initial respiratory extracorporeal life support alone compared to cardiac or cardiorespiratory extracorporeal life support associate with lower hospital and intensive care unit mortality in patients with severe ARDS?
Meta-Analysis (n=5,875)
Yes
Does initial respiratory extracorporeal life support alone compared to cardiac or cardiorespiratory extracorporeal life support associate with lower hospital and intensive care unit mortality in patients with severe ARDS?
In patients with severe ARDS, the need for cardiac or cardiorespiratory extracorporeal life support is associated with significantly higher hospital and ICU mortality compared to respiratory support alone, likely driven by greater baseline illness severity and haemodynamic compromise.
Answers are grounded in this paper and cite their sources.
Should not yet change ECLS configuration in ARDS; observational data with unadjusted confounders leave open independent effects of support type.
Introduction Venovenous extracorporeal membrane oxygenation is established support for severe acute respiratory distress syndrome with refractory respiratory failure, but some patients also have circulatory failure and receive cardiac or cardiorespiratory extracorporeal life support. Mortality in this group is poorly defined. Methods We conducted a systematic review and random-effects meta-analysis of observed hospital and intensive care unit mortality according to the initial extracorporeal life support configuration, with certainty of evidence assessed using GRADE. Odds ratios are expressed for respiratory support relative to cardiac or cardiorespiratory support, so that a value below 1 indicates lower mortality with respiratory support alone. Results Twelve observational studies contributed data from 5,875 patients. Hospital mortality was lower with respiratory support (9 studies; odds ratio 0.59, 95% confidence interval 0.37–0.92; I 2 = 62.5%; 95% prediction interval 0.21–1.60; low-certainty evidence), as was intensive care unit mortality (5 studies; odds ratio 0.40, 95% confidence interval 0.23–0.69; very-low-certainty evidence). The cohorts were clinically heterogeneous and rarely adjusted for shock severity, vasoactive support, lactate, cardiac function or general severity scores. Conclusions Because the configuration was selected in response to haemodynamic compromise and may also reflect centre practice, these pooled estimates describe an association and not the effect of an extracorporeal support strategy. Higher observed mortality in patients receiving cardiac or cardiorespiratory support is likely to be explained in large part by greater baseline illness severity and residual confounding.
No takes yet. Share an insight, caveat, or question.
Badawy et al. (2026) conducted a meta-analysis in Severe acute respiratory distress syndrome (ARDS) with circulatory or refractory respiratory failure requiring extracorporeal life support (n=5,875). Respiratory extracorporeal life support alone (venovenous ECMO) vs. Cardiac or cardiorespiratory extracorporeal life support was evaluated on Hospital mortality (OR 0.59, 95% CI 0.37-0.92). Respiratory extracorporeal support alone was associated with lower hospital mortality than cardiac or cardiorespiratory support in ARDS.
Synapse has enriched 10 related papers. Consider them for comparative context: